# The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2

> **NCT04970940** · PHASE1 · COMPLETED · sponsor: **AJU Pharm Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- T2DM (Type 2 Diabetes Mellitus)

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B
- **DRUG:** Treatment C

## Key facts

- **NCT ID:** NCT04970940
- **Lead sponsor:** AJU Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-02
- **Primary completion:** 2020-10-07
- **Final completion:** 2020-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04970940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04970940, "The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04970940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*